These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6258184)

  • 1. Regulation of cyclic AMP levels in human lymphocytes and lymphoblasts by prostaglandins.
    Fadda S; Mastacchi R; Romeo G; Tomasi V; Barnabei O
    Prostaglandins Med; 1980 Dec; 5(6):477-86. PubMed ID: 6258184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 6-keto-prostaglandin E1 on human lymphocyte cAMP levels.
    Mastacchi R; Fadda S; Tomasi V; Barnabei O
    Prostaglandins Med; 1980 Dec; 5(6):487-94. PubMed ID: 6258185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of steroids on the regulation of the levels of cyclic AMP in human lymphocytes.
    Lee TP; Reed CE
    Biochem Biophys Res Commun; 1977 Oct; 78(3):998-1004. PubMed ID: 199195
    [No Abstract]   [Full Text] [Related]  

  • 4. beta-adrenergic catecholamine regulation of lymphocyte sensitivity: heterologous desensitization to prostaglandin E2 by isoproterenol.
    Tuck ML; Fittingoff D; Connelly M; Krall JF
    J Clin Endocrinol Metab; 1980 Jul; 51(1):1-6. PubMed ID: 6103901
    [No Abstract]   [Full Text] [Related]  

  • 5. Alzheimer's disease: isoproterenol and prostaglandin E1-stimulated cyclic AMP accumulation in lymphocytes.
    Ebstein RP; Oppenheim G; Stessman J
    Life Sci; 1984 Jun; 34(23):2239-43. PubMed ID: 6145077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of caffeine withdrawal on isoproterenol-stimulated cyclic adenosine monophosphate.
    Mackenzie TB; Popkin MK; Dziubinski J; Sheppard JR
    Clin Pharmacol Ther; 1981 Oct; 30(4):436-8. PubMed ID: 6269786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired lymphocyte cyclic adenosine monophosphate responses in atopic eczema.
    Archer CB; Morley J; MacDonald DM
    Br J Dermatol; 1983 Nov; 109(5):559-64. PubMed ID: 6315045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels.
    Pontecorvo EG; Myers CB; Lippton HL; Kadowitz PJ
    Prostaglandins Med; 1981 May; 6(5):473-83. PubMed ID: 6267636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic adenine nucleotide levels in lymphocytes from patients with systemic sclerosis: efficiency of prostaglandin infusions.
    Kovacs IB; Dowd PM; Kirby JD; Turner P
    Postgrad Med J; 1983 Apr; 59(690):241-3. PubMed ID: 6306626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB; Harden TK
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of beta-adrenergic response in human lymphocytes: agonist induced subsensitivity.
    Lee TP
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):233-42. PubMed ID: 216063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of mitogen-induced lymphocyte proliferation after preincubation is due to altered sensitivity to prostaglandins.
    Kalmár L; Gergely P
    Immunol Lett; 1982 Apr; 4(4):179-83. PubMed ID: 6284639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal monocyte cytotoxicity and cyclic-AMP levels in systemic sclerosis.
    Herlin T; Eggert J; Kragballe K; Zachariae H
    Arch Dermatol Res; 1984; 276(5):279-82. PubMed ID: 6091571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone and forskolin-stimulated cyclic AMP accumulation in human lymphocytes: reliability of longitudinal time measurements.
    Ebstein RP; Mintzer J; Lipschitz Y; Shemesh Z; Stessman J
    Experientia; 1986 Jul; 42(7):838-41. PubMed ID: 3015668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness.
    Grewe SR; Chan SC; Hanifin JM
    J Allergy Clin Immunol; 1982 Dec; 70(6):452-7. PubMed ID: 6128357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of the effect of ephedrine on levels of cyclic adenosine monophosphate in human lymphocytes.
    Lee TP; Reed CE
    J Allergy Clin Immunol; 1977 Aug; 60(2):141-3. PubMed ID: 194936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV; Aiken JW; Shebuski RJ; Gorman RR
    Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of benzidamine, prostacyclin and isoproterenol on the cAMP levels in human lymphocytes].
    Nencini P
    Minerva Stomatol; 1981; 30(6):625-8. PubMed ID: 6276706
    [No Abstract]   [Full Text] [Related]  

  • 19. Histamine H2 receptor activity during the differentiation of the human monocytic-like cell line U-937. Comparison with prostaglandins and isoproterenol.
    Gespach C; Cost H; Abita JP
    FEBS Lett; 1985 May; 184(2):207-13. PubMed ID: 2581807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prostaglandins on cyclic AMP levels of human peripheral lymphocytes and rat thymocytes.
    Bartolini G; Tomasi V; Orlandi M
    Boll Soc Ital Biol Sper; 1984 May; 60 Suppl 4():99-104. PubMed ID: 6147151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.